Skip to main content
TipRanks
Go Ultimate75% OFF

Aptevo Therapeutics (AP82) Q2 2023 Earnings Report

0 Followers

DE:AP82 Q2 2023 EPS Results

Actual EPS
-EUR 645,438.28
Consensus EPS
-EUR 587,716.16
Beat/Miss
Missed by -EUR 57,722.12
One Year Ago EPS
EUR 2,912,520.83

DE:AP82 Q2 2023 Revenue Results

Actual Revenue
EUR 0
Expected Revenue
EUR 0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2023
Date
08/10/2023
Time
Before Open
Conference Call
Thursday, August 10, 2023
DE:AP82 Upcoming Earnings

Aptevo Therapeutics's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

Q2 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:AP82 Earnings History

DE:AP82 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Apr 01, 20272026 (Q4)―--5.74――
Nov 05, 20262026 (Q3)-3.33--35.94―
Aug 14, 20262026 (Q2)-5.39-4.75-135.3896.49% (+130.62)
May 07, 20262026 (Q1)-5.01-5.74-1415.0199.59% (+1409.27)
Mar 26, 20262025 (Q4)―1508.19-2881.59152.34% (+4389.78)
Nov 06, 20252025 (Q3)-33.68-35.94-5724.5199.37% (+5688.57)
Aug 11, 20252025 (Q2)-1340.88-135.38-19916.5299.32% (+19781.14)
May 15, 20252025 (Q1)-1356.99-1415.01-118664.2898.81% (+117249.27)
Feb 14, 20252024 (Q4)-2498.03-2881.59-160166.9698.20% (+157285.37)
Nov 07, 20242024 (Q3)-6797.85-5724.51-262373.2897.82% (+256648.78)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed